Literature DB >> 1409662

Prevention of autoimmune insulitis in nonobese diabetic mice by expression of major histocompatibility complex class I Ld molecules.

T Miyazaki1, Y Matsuda, T Toyonaga, J Miyazaki, Y Yazaki, K Yamamura.   

Abstract

Nonobese diabetic (NOD) mice spontaneously develop a T-cell-mediated autoimmune disease that is similar in many respects to insulin-dependent diabetes mellitus in humans. NOD mice were shown to express major histocompatibility complex class I Kd and Db antigens. To examine the possible involvement of major histocompatibility complex class I molecules in the development of autoimmune insulitis, we attempted to express a different type of class I molecule in NOD mice by crossing C57BL/6 mice transgenic for the class I Ld gene with NOD mice. The backcross progeny expressed the Ld antigen on the peripheral blood lymphocytes at a level comparable with that of the BALB/c mice. The cell surface expression of endogenous class I and class II antigens on the peripheral blood lymphocytes was not affected. Analysis of these mice revealed that the expression of the class I Ld antigen significantly reduced the incidence of insulitis at 20 weeks of age. In situ hybridization of a biotinylated probe on mouse chromosomes showed that the Ld transgene was located in the E area of chromosome 6 with which no genetic linkage to insulin-dependent diabetes mellitus was demonstrated. These results suggest that the NOD-type class I molecules are involved in the development of insulitis in NOD mice.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1409662      PMCID: PMC50163          DOI: 10.1073/pnas.89.20.9519

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  54 in total

1.  T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins.

Authors:  B O Roep; S D Arden; R R de Vries; J C Hutton
Journal:  Nature       Date:  1990-06-14       Impact factor: 49.962

2.  Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice.

Authors:  T Miyazaki; M Uno; M Uehira; H Kikutani; T Kishimoto; M Kimoto; H Nishimoto; J Miyazaki; K Yamamura
Journal:  Nature       Date:  1990-06-21       Impact factor: 49.962

3.  HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus.

Authors:  J A Todd; J I Bell; H O McDevitt
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

4.  Overexpression of beta 2-microglobulin in transgenic mouse islet beta cells results in defective insulin secretion.

Authors:  J Allison; L Malcolm; J Culvenor; R K Bartholomeusz; K Holmberg; J F Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

5.  Prevention of cyclophosphamide-induced and spontaneous diabetes in NOD/Shi/Kbe mice by anti-MHC class I Kd monoclonal antibody.

Authors:  T Taki; M Nagata; W Ogawa; N Hatamori; M Hayakawa; J Hari; K Shii; S Baba; K Yokono
Journal:  Diabetes       Date:  1991-09       Impact factor: 9.461

6.  Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response.

Authors:  M B Oldstone; M Nerenberg; P Southern; J Price; H Lewicki
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

7.  Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.

Authors:  P S Ohashi; S Oehen; K Buerki; H Pircher; C T Ohashi; B Odermatt; B Malissen; R M Zinkernagel; H Hengartner
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

8.  In situ analysis of centromeric satellite DNA segregating in Mus species crosses.

Authors:  Y Matsuda; V M Chapman
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

9.  Suppression of murine leukemia virus-mediated 3Y1 cell fusion by expression of mouse MHC class I.

Authors:  N Momozaki; H Ogura; J Miyazaki; S Matsuhashi; K Joh; G Kimura; K Tabuchi; K Hori
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

10.  Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse.

Authors:  L S Wicker; B J Miller; L Z Coker; S E McNally; S Scott; Y Mullen; M C Appel
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

View more
  9 in total

1.  Class I HLA is associated with age-at-onset of IDDM, while class II HLA confers susceptibility to IDDM.

Authors:  T Fujisawa; H Ikegami; Y Kawaguchi; E Yamato; K Takekawa; Y Nakagawa; Y Hamada; H Ueda; K Shima; T Ogihara
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

2.  Predominant occupation of the class I MHC molecule H-2Kwm7 with a single self-peptide suggests a mechanism for its diabetes-protective effect.

Authors:  Daniel R Brims; Jie Qian; Irene Jarchum; Leann Mikesh; Edith Palmieri; Udupi A Ramagopal; Vladimir N Malashkevich; Rodolfo J Chaparro; Torben Lund; Masakazu Hattori; Jeffrey Shabanowitz; Donald F Hunt; Stanley G Nathenson; Steven C Almo; Teresa P Dilorenzo
Journal:  Int Immunol       Date:  2010-01-21       Impact factor: 4.823

Review 3.  Dissecting autoimmune diabetes through genetic manipulation of non-obese diabetic mice.

Authors:  Y Yang; P Santamaria
Journal:  Diabetologia       Date:  2003-10-28       Impact factor: 10.122

4.  Identification of a new susceptibility locus for insulin-dependent diabetes mellitus by ancestral haplotype congenic mapping.

Authors:  H Ikegami; S Makino; E Yamato; Y Kawaguchi; H Ueda; T Sakamoto; K Takekawa; T Ogihara
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

Review 5.  Current status and prospects for gene and cell therapeutics for type 1 diabetes mellitus.

Authors:  Nick Giannoukakis; Massimo Trucco
Journal:  Rev Endocr Metab Disord       Date:  2003-12       Impact factor: 9.306

6.  Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities.

Authors:  F Lühder; J Katz; C Benoist; D Mathis
Journal:  J Exp Med       Date:  1998-02-02       Impact factor: 14.307

Review 7.  Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases.

Authors:  Jean-François Bach
Journal:  Arthritis Res       Date:  2002-05-09

8.  Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression.

Authors:  Michael A Brehm; Laurie L Kenney; Michael V Wiles; Benjamin E Low; Roland M Tisch; Lisa Burzenski; Christian Mueller; Dale L Greiner; Leonard D Shultz
Journal:  FASEB J       Date:  2018-11-01       Impact factor: 5.834

9.  Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes.

Authors:  P Panina-Bordignon; R Lang; P M van Endert; E Benazzi; A M Felix; R M Pastore; G A Spinas; F Sinigaglia
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.